宫腔镜在子宫内膜癌高危因素评估中的应用进展

doi:10.3969/j.issn.1006-7795.2021.02.009

摘要/Abstract

摘要： 子宫内膜癌是最常见的妇科恶性肿瘤之一,术前对其高危因素的准确评估是制定个体化治疗方案的基础。宫腔镜在对子宫内膜癌组织分化程度、宫颈受累情况、内膜癌病灶大小以及子宫内膜癌前哨淋巴结的评估中提供了准确、有价值的信息,对制定个体化手术方案、改善患者预后具有十分重要的意义。

关键词: 子宫内膜癌, 高危因素, 宫腔镜, 评估

Abstract: Endometrial cancer is one of the most common gynecological malignancies. Accurate assessment of its high-risk factors before surgery is the basis for treatment. Hysteroscopy provides valuable information on evaluation of endometrial cancer tissue differentiation, cervical involvement, and the size of endometrial cancer lesions. Hysteroscopic-injection of tracer is an accurate method for sentinel lymph nodes mapping. The above information is very important for formulating individualized surgical plans to improve patient prognosis.

Key words: endometrial cancer, high-risk factors, hysteroscopy, evaluation

中图分类号:

R737.33

张颖, 段华. 宫腔镜在子宫内膜癌高危因素评估中的应用进展[J]. 首都医科大学学报, 2021, 42(2): 214-218.

Zhang Ying, Duan Hua. Progress of hysteroscopy application in the evaluation of high risk factors of endometrial cancer[J]. Journal of Capital Medical University, 2021, 42(2): 214-218.

参考文献

[1] Lu K H, Broaddus R R.Endometrial cancer[J]. N Engl J Med, 2020,383(21):2053-2064.
[2] 周琦,吴小华,刘继红,等.子宫内膜癌诊断与治疗指南(第四版)[J].中国实用妇科与产科杂志,2018,34(8):880-886.
[3] Brasseur K, Gévry N, Asselin E.Chemoresistance and targeted therapies in ovarian and endometrial cancers[J]. Oncotarget,2017,8(3):4008-4042.
[4] Török P, Molnár S, Lampé R, et al.The use of hysteroscopy in endometrial cancer: old questions and novel challenges[J]. Climacteric, 2020,23(4):330-335.
[5] Török P, Molnár S, Lampé R, et al.The use of hysteroscopy in endometrial cancer: old questions and novel challenges[J]. Climacteric, 2020,23(4):330-335.
[6] Ianieri M M, Staniscia T, Pontrelli G,et al.A new hysteroscopic risk scoring system for diagnosing endometrial hyperplasia and adenocarcinoma[J]. J Minim Invasive Gynecol, 2016,23(5):712-718.
[7] Wang W, Chen F, Kong L, et al.Prospective evaluation of the accuracy of a training program in image recognition by narrow-band imaging guided hysteroscopy of endometrial neoplasms[J]. Gynecol Obstet Invest, 2020,85(3):284-289.
[8] Nasioudis D, Heyward Q D, Haggerty A F, et al.Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer[J]. Surg Oncol, 2020, 34:7-12.
[9] Murali R, Davidson B, Fadare O, et al. High-grade endometrial carcinomas: Morphologic and immunohistochemical features, diagnostic challenges and recommendations[J]. Int J Gynecol Pathol, 2019,38 Suppl 1(Iss 1 Suppl 1):S40-S63.
[10] Bonatti M, Pedrinolla B, Cybulski A J, et al.Prediction of histological grade of endometrial cancer by means of MRI[J]. Eur J Radiol,2018,103:44-50.
[11] Yan B, Zhao T, Liang X, et al.Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?[J]. Acta Radiol,2018,59(3):363-370.
[12] Visser N C M, Reijnen C, Massuger L F A G, et al. Accuracy of endometrial sampling in endometrial carcinoma: A systematic review and Meta-analysis[J]. Obstet Gynecol,2017,130(4):803-813.
[13] Miyamoto T, Abiko K, Murakami R, et al.Hysteroscopic morphological pattern reflects histological grade of endometrial cancer[J]. J Obstet Gynaecol Res, 2019, 45(8):1479-1487.
[14] Su H, Pandey D, Liu L Y, et al.Pattern recognition to prognosticate endometrial cancer: The Science Behind the Art of Office Hysteroscopy-A Retrospective Study[J]. Int J Gynecol Cancer,2016,26(4):705-710.
[15] Pecorelli S.Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet,2009,105(2):103-104.
[16] Ørtoft G, Dueholm M, Mathiesen O, et al.Preoperative staging of endometrial cancer using TVS, MRI, and hysteroscopy[J]. Acta Obstet Gynecol Scand,2013,92(5):536-545.
[17] 李小毛,杨晓辉,杨越波,等. 宫腔镜辅助分段诊刮术在子宫内膜癌诊断中的价值[J]. 中华妇产科杂志,2015,50(2):120-124.
[18] Teng F, Zhang Y F, Wang Y M, et al.Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma[J]. Acta Obstet Gynecol Scand, 2015,94(3):266-273.
[19] Sozzi G, Uccella S, Berretta R,et al.Tumor size, an additional risk factor of local recurrence in low-risk endometrial cancer: a large multicentric retrospective study[J]. Int J Gynecol Cancer,2018,28(4):684-691.
[20] Mandato V D, Torricelli F, Mastrofilippo V, et al.Accuracy of preoperative endometrial biopsy and intraoperative frozen section in predicting the final pathological diagnosis of endometrial cancer[J]. Surg Oncol, 2020,35:229-235.
[21] Smith B Q, Boone J D, Thomas E D, et al.The reliability of intraoperative assessment on predicting tumor size, myometrial invasion, and cervical involvement in patients with a preoperative diagnosis of complex atypical hyperplasia or (clinical stage I) endometrial cancer: A Prospective Cohort Study[J]. Am J Clin Oncol,2020,43(2):122-127.
[22] Gülseren V, Kocaer M, Çelikkol,et al. Is the measurement of the size of uterine lesions with positron emission tomography consistent in pre- and postmenopausal periods in endometrioid-type endometrial cancer?[J]. Turk J Obstet Gynecol,2018,15(1):60-64.
[23] Song Y, Shang H, Ma Y, et al.Can conventional DWI accurately assess the size of endometrial cancer?[J]. Abdom Radiol (NY), 2020,45(4):1132-1140.
[24] 杨媛,赵丽君,王志启,等. 阴道超声、MRI及宫腔镜检查测量子宫内膜癌病灶大小的临床意义[J]. 中华妇产科杂志,2016,51(1):36-39.
[25] Zorzato P C, Bosco M, Franchi M P, et al.Sentinel lymph-node for endometrial cancer treatment: review of literature[J]. Minerva Med,2021,112(1):70-80.
[26] Mariani A, Dowdy S C, Cliby W A,et al.Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging[J]. Gynecol Oncol,2008,109(1):11-18.
[27] Guo J, Qian H, Ma F, et al.The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance[J]. Ther Adv Med Oncol, 2020,12:1758835920933036.
[28] Cormier B, Rozenholc A T, Gotlieb W,et al.Communities of Practice (CoP) Group of Society of Gynecologic Oncology of Canada (GOC). Sentinel lymphnode procedure in endometrial cancer: A systematic review and proposal for standardization of future research[J]. Gynecol Oncol,2015,138(2):478-485.
[29] Gezer Ş,Duman Öztürk S, Hekimsoy T, et al.Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial[J]. Int J Gynecol Cancer, 2020,30(3):325-331.
[30] Martinelli F, Ditto A, Signorelli M, et al.Sentinel node mapping in endometrial cancer following Hysteroscopic injection of tracers: A single center evaluation over 200 cases[J]. Gynecol Oncol,2017,146(3):525-530.
[31] El-Agwany A S, Meleis M H. Value and best way for detection of Sentinel lymphnode in early stage endometrial cancer: Selective lymphadenectomy algorithm[J]. Eur J Obstet Gynecol Reprod Biol,2018,225:35-39.
[32] Martinelli F, Ditto A, Bogani G,et al.Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers[J]. Int J Gynecol Cancer, 2020,30(3):332-338.